August 6 (SeeNews) - Slovenian blue-chip drug maker Krka may acquire a big peer in order to raise its market share or diversify its offer, and can afford to spend up to 1.5 billion euro ($2.3 billion) on the acquisition, the company’s CEO Joze Colaric told local daily Dnevnik.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
